Gain Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Gain Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
  • Gain Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -128 %, a 12.1% decline year-over-year.
  • Gain Therapeutics, Inc. annual Return On Assets for 2023 was -123 %, a 113% decline from 2022.
  • Gain Therapeutics, Inc. annual Return On Assets for 2022 was -57.7 %, a 81.7% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -128 -13.8 -12.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -130 -34.1 -35.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -129 -55.4 -75.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -123 -65.5 -113% Oct 1, 2023 Dec 31, 2023
Q3 2023 -114 -67.1 -142% Jul 1, 2023 Sep 30, 2023
Q2 2023 -95.9 -52.9 -123% Apr 1, 2023 Jun 30, 2023
Q1 2023 -73.7 -37.9 -106% Jan 1, 2023 Mar 31, 2023
Q4 2022 -57.7 -26 -81.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.2 -13.3 -39.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -43 Apr 1, 2022 Jun 30, 2022
Q1 2022 -35.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.8 Oct 1, 2021 Dec 31, 2021
Q3 2021 -33.9 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.